BioSpace News Archive

Promising clinical durability observed with 80% of wet AMD treated eyes and 78% of DME treated eyes extended to four months or longer without receiving retreatment

The Medicrea Group (Euronext Growth Paris - FR0004178572 - ALMED; OTCQX Best Market – MRNTF), pioneering the digital transformation of spinal surgery through artificial Intelligence, predictive modeling and patient specific implants with its UNiD ASI™ (Adaptive Spine Intelligence) proprietary software platform, services and technologies, publishes sales for the third quarter of 2019.

Dutch Medtech company IME Medical Electrospinning, worldwide leader and scientific partner in electrospinning solutions for medical devices and controlled drug delivery, has appointed three new members to its Board of Directors to help further develop its strategy and drive its growing business in the medical device sector as well as in the Biopharmaceutical sector

bioAffinity Technologies, a privately held biotech company, today announced that it has been accepted as a member of the American Cancer Society’s National Lung Cancer Roundtable (NLCRT), a collaborative whose membership is focused on reducing both the incidence of lung cancer and mortality rates from the disease.

Profound Medical Corp. (TSX: PRN; OTCQX: PRFMF) (“Profound” or the “Company”) is pleased to announce that today it implemented a consolidation (the “Consolidation”) of its issued and outstanding common shares (“Common Shares”) on the basis of one post-Consolidation Common Share for every ten pre-Consolidation Common Shares.

News media representatives are invited to attend a major press conference on Monday, Oct. 21, 2019 where C Spire executives and state medical leaders will unveil an innovative approach for removing barriers to quick, reliable access to health care for Mississippi residents, especially those in rural and underserved areas.

Leon Medical Centers Health Plans has achieved five out of five Stars for quality and performance from the Centers for Medicare & Medicaid Services (CMS) in the organization’s annual ratings.

BioLab Sciences, a regenerative biotechnology company that is creating new ways to regenerate the body for optimal performance, is garnering national attention with a culmination of industry awards for its MyOwn Skin™ product, a regenerative solution for wound care

Turn Therapeutics™, Inc., a Los Angeles-based pharmaceutical and medical device company, has announced FDA clearance of Protego™ Antimicrobial Wound Dressing, an important and disruptive innovation to traditional petroleum saturated gauze dressings.

Rezolute, Inc., announced that senior management will present at the 2019 BIO Investor Forum Conference in San Francisco on Tuesday, October 22, 2019 at 9:00 a.m. PT.